Factor XI antibodies and methods of use

The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI ("Factor XIa"), and pharmaceutical compositions and methods of treatment comprising the same.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Koch, Alexander Wolfgang, Aigner, Maximilian, Waldhuber, Markus
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Koch, Alexander Wolfgang
Aigner, Maximilian
Waldhuber, Markus
description The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI ("Factor XIa"), and pharmaceutical compositions and methods of treatment comprising the same.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US12012464B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US12012464B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US12012464B23</originalsourceid><addsrcrecordid>eNrjZFB3S0wuyS9SiPBUSMwryUzKT8lMLQYyUxRyU0sy8lOKFfLTFEqLU3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGRgaGRiZmJk5ExMWoAVygnVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Factor XI antibodies and methods of use</title><source>esp@cenet</source><creator>Koch, Alexander Wolfgang ; Aigner, Maximilian ; Waldhuber, Markus</creator><creatorcontrib>Koch, Alexander Wolfgang ; Aigner, Maximilian ; Waldhuber, Markus</creatorcontrib><description>The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI ("Factor XIa"), and pharmaceutical compositions and methods of treatment comprising the same.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240618&amp;DB=EPODOC&amp;CC=US&amp;NR=12012464B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240618&amp;DB=EPODOC&amp;CC=US&amp;NR=12012464B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Koch, Alexander Wolfgang</creatorcontrib><creatorcontrib>Aigner, Maximilian</creatorcontrib><creatorcontrib>Waldhuber, Markus</creatorcontrib><title>Factor XI antibodies and methods of use</title><description>The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI ("Factor XIa"), and pharmaceutical compositions and methods of treatment comprising the same.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB3S0wuyS9SiPBUSMwryUzKT8lMLQYyUxRyU0sy8lOKFfLTFEqLU3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGRgaGRiZmJk5ExMWoAVygnVQ</recordid><startdate>20240618</startdate><enddate>20240618</enddate><creator>Koch, Alexander Wolfgang</creator><creator>Aigner, Maximilian</creator><creator>Waldhuber, Markus</creator><scope>EVB</scope></search><sort><creationdate>20240618</creationdate><title>Factor XI antibodies and methods of use</title><author>Koch, Alexander Wolfgang ; Aigner, Maximilian ; Waldhuber, Markus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US12012464B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Koch, Alexander Wolfgang</creatorcontrib><creatorcontrib>Aigner, Maximilian</creatorcontrib><creatorcontrib>Waldhuber, Markus</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Koch, Alexander Wolfgang</au><au>Aigner, Maximilian</au><au>Waldhuber, Markus</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Factor XI antibodies and methods of use</title><date>2024-06-18</date><risdate>2024</risdate><abstract>The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI ("Factor XIa"), and pharmaceutical compositions and methods of treatment comprising the same.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US12012464B2
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title Factor XI antibodies and methods of use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A02%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Koch,%20Alexander%20Wolfgang&rft.date=2024-06-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS12012464B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true